Lupin launches generic SynthroidLevothyroxine sodium tablets had a market value of roughly $2.5 billion, according to January 2019 IQVIA data. FDA clears Lupin’s generic ViagraThe erectile dysfunction treatment had a market value of $611 million, according to December 2018 IQVIA data. Teva launches generic Exjade Exjade had a market value of $134 million for the year ended December 2018, according to IQVIA data. Slayback gets FDA nod for single-dose generic Makena The company previously launched its generic Makena in a 5 ml multidose vial. Zydus Cadila receives FDA nod for generic Latuda Zydus Cadila's generic Latuda tablets provide a treatment for certain mental/mood disorders. Biologics by McKesson to exclusively distribute Cablivi Biologics by McKesson is expanding its specialty pharmacy’s footprint beyond oncology. Jazz Pharmaceuticals gets FDA nod for Sunosi Sunosi provides a treatment for obstructive sleep apnea and narcolepsy patients with excessive daytime sleepiness. NACDS launches online resource to aid states, pharmacies in optimizing care The online NACDS Optimizing Care Process Guide is intended to advance pharmacy care for patients, the organization said. PTCB expands credentialing programs for advanced technician roles The PTCB is rolling out five new assessment-based certificate programs and a CPhT-Adv credential. FDA approves new indication for Roche’s Tecentriq Tecentriq is the first cancer immunotherapy approved for the initial treatment of extensive-stage small-cell lung cancer First Previous 13 14 15 16 17 Next Last
